Article Type
Article
Changed
Thu, 12/15/2022 - 15:09
Display Headline
Clobetasol Propionate Spray 0.05% for the Treatment of Moderate to Severe Plaque Psoriasis
Author(s)
Menter A

Article PDF
089020089.pdf
Author and Disclosure Information

Menter A

Issue
Cutis - 89(2)
Publications
Cutis
MDedge Dermatology
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Page Number
89-94
Legacy Keywords
Clobetasol Propionate Spray 0.05%, Clobex spray, severe plaque psoriasis, Community Based Research Assessment, COBRA, Alan Menter
Sections
Original Research
Clinical Topics & News
Author(s)
Menter A
Author(s)
Menter A
Author and Disclosure Information

Menter A

Author and Disclosure Information

Menter A

Article PDF
089020089.pdf
Article PDF
089020089.pdf

Issue
Cutis - 89(2)
Issue
Cutis - 89(2)
Page Number
89-94
Page Number
89-94
Publications
Cutis
MDedge Dermatology
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
Cutis
MDedge Dermatology
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Article Type
Article
Display Headline
Clobetasol Propionate Spray 0.05% for the Treatment of Moderate to Severe Plaque Psoriasis
Display Headline
Clobetasol Propionate Spray 0.05% for the Treatment of Moderate to Severe Plaque Psoriasis
Legacy Keywords
Clobetasol Propionate Spray 0.05%, Clobex spray, severe plaque psoriasis, Community Based Research Assessment, COBRA, Alan Menter
Legacy Keywords
Clobetasol Propionate Spray 0.05%, Clobex spray, severe plaque psoriasis, Community Based Research Assessment, COBRA, Alan Menter
Sections
Original Research
Clinical Topics & News
Article Source

PURLs Copyright

Inside the Article

Article PDF Media